Amgen Loses Battle In Anemia War With La Roche
Marking another chapter in an epic battle over the multi-billion dollar market for anemia treatments, an judge with the International Trade Commission has rejected Amgen Inc.'s bid to bar rival drugmaker...To view the full article, register now.
Already a subscriber? Click here to view full article